Caxton CORP — Q1 2023 13F Holdings

Name: Caxton CORP — 13F Holdings, Q1 2023
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001388551

Total reported value

$4.0M

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	SVRA	Savara INC	Stock-Other	33.97%	—	—
2	XERS	Xeris Biopharma Holdings INC	Stock-Other	24.86%	—	—
3	SPY	Ss Spdr S&p 500 ETF Trust-us	ETF-Large Cap & Growth	16.49%	—	—
4	RZLT	Rezolute INC	Stock-Other	6.80%	—	—
5	XOP	Ss Spdr S&p Og Exp & Prod	ETF-Other	5.64%	—	—
6	✓	Vectivbio Holding	Stock-Other	3.40%	—	+0.27%
7	AMLP	Alerian Mlp ETF	ETF-Other	2.88%	—	—
8	✓	Molecular Templates Inc	Stock-Other	1.97%	—	—
9	CMPX	Compass Therapeutics INC	Stock-Other	1.71%	-3.70%	EXIT
10	ALLKGUSD	Allakos INC	Stock-Other	0.97%	—	+373.61%
11	CABA	Cabaletta Bio INC	Stock-Other	0.85%	—	-52.10%
12	✓	Elevation Oncology INC	Stock-Other	0.33%	—	—
13	✓	Newamsterdam Pharma Company	Stock-Other	0.10%	—	—
14	✓	Moneyhero Limited Wt Exp 091328	Stock-Other	0.02%	—	—
15	✓	Lanvin Group Holdings Limite	Stock-Other	0.01%	—	—

Position changes disclosed by Caxton CORP for the quarter ending Q1 2023, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	SVRA	Savara INC	+6.7%	—	Unchanged
2	XERS	Xeris Biopharma Holdings INC	+4.3%	—	Unchanged
3	SPY	Ss Spdr S&p 500 ETF Trust-us	+0.9%	—	Unchanged
4	ALLKGUSD	Allakos INC	+0.6%	+373.61%	Add
5	✓	Molecular Templates Inc	+0.3%	—	Unchanged
6	✓	Elevation Oncology INC	+0.2%	—	Unchanged
7	✓	Newamsterdam Pharma Company	+0.1%	—	Unchanged
8	AMLP	Alerian Mlp ETF	0%	—	Unchanged
9	✓	Moneyhero Limited Wt Exp 091328	0%	—	Unchanged
10	✓	Lanvin Group Holdings Limite	—	—	Unchanged
11	✓	Vectivbio Holding	0%	+0.27%	Add
12	XOP	Ss Spdr S&p Og Exp & Prod	-0.4%	—	Unchanged
13	RZLT	Rezolute INC	-0.6%	—	Unchanged
14	CMPX	Compass Therapeutics INC	-1%	+0.28%	Add
15	CABA	Cabaletta Bio INC	-1.2%	-52.10%	Trim
16	ACLXGBX	Arcellx INC	-2.9%	EXIT	Sold out
17	SCYXEUR	Scynexis INC	-6.9%	EXIT	Sold out